These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7128801)

  • 1. Molecular requirements of the active sites of the cholinergic receptors. XVIII-Correlation between activity and double bond position among cyclopentene derivatives.
    Brasili L; Leonelli M; Giannella M
    Farmaco Sci; 1982 Jul; 37(7):431-7. PubMed ID: 7128801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular requirements of the active site of cholinergic receptors XV: Synthesis and biological activity of 2,3-dehydrodeoxamuscarone and 2,3-dehydrodeoxamuscarines.
    Angeli P; Brasili L; Giardinà D; Melchiorre C
    J Pharm Sci; 1981 May; 70(5):489-92. PubMed ID: 7241348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular requirements of the active sites of the cholinergic receptors. XII - 3-Methyl-2-oxo-1-dimethylaminomethylcyclopentane methiodide as a new selective agonist for the nicotinic receptor.
    Giannella M; Angeli P; Melchiorre C; Brasili L
    Farmaco Sci; 1980 Apr; 35(4):253-62. PubMed ID: 6450060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular requirements of the active sites of the cholinergic receptors. XIX-Size evaluation of the muscarinic subsite.
    Gualtieri F; Brasili L; Giannella M; Pigini M
    Farmaco Sci; 1982 Sep; 37(9):618-26. PubMed ID: 7128816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular requirements of the active sites of the cholinergic receptors. XVI - Synthesis and cholinergic activity of 2- or 5-alkyl or 5-phenyl-4-methyl-3-oxo-1-dimethylaminomethylcyclopentane methiodide.
    Pigini M; Brasili L
    Farmaco Sci; 1981 Feb; 36(2):152-8. PubMed ID: 7227502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic thioligands with cyclopentane nucleus.
    Piergentili A; Pigini M; Quaglia W; Tayebati SK; Amenta F; Sabbatini M; Giannella M
    Bioorg Med Chem; 1996 Dec; 4(12):2193-9. PubMed ID: 9022982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular requirements of the active sites of the cholinergic receptors. XI - Synthesis and biological evaluation of isomuscarie and its isomers.
    Pigini M; Ballini R; Gualtieri F; Brasili L
    Farmaco Sci; 1980 Mar; 35(3):167-80. PubMed ID: 6450059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic compounds. III - Synthesis and biological activity of epi-desmethyldesethermuscarine, desmethyldesethermuscarine and desmethyldesethermuscarone.
    Melchiorre C; Gualtieri F; Giannella M; Pigini M; Cingolani ML; Gamba G; Pigini P; Rossini L
    Farmaco Sci; 1975 Apr; 30(4):287-99. PubMed ID: 1183606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic compounds. V - New synthesis and further pharmacological evaluation of desethermuscarine.
    Melchiorre C; Gualtieri F; Giannella M; Pigini M; Cingolani ML; Gamba G; Pigini P; Rossini L
    Farmaco Sci; 1975 Apr; 30(4):300-10. PubMed ID: 1183607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular requirements of the active sites of the cholinergic receptors. XIII - Stereospecific synthesis of 3c-methyl-2t-hydroxy-lr-dimethyl-aminomethylcyclopentane methiodide and its dehydroderivative.
    Giannella M; Leonelli M; Pigini M
    Farmaco Sci; 1980 Apr; 35(4):263-8. PubMed ID: 6450061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic compounds. 9. Cyclohexane analogues of deoxamuscarine and derivatives.
    Angeli P; Melchiorre C; Giannella M; Pigini M; Cingolani ML
    J Med Chem; 1977 Mar; 20(3):398-400. PubMed ID: 845872
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular interactions at the cholinergic receptor in neuromuscular blockade.
    Stenlake JB
    Prog Med Chem; 1979; 16():257-86. PubMed ID: 400617
    [No Abstract]   [Full Text] [Related]  

  • 13. Ligand specificity of state transitions in the cholinergic receptor: behavior of agonists and antagonists.
    Weiland G; Taylor P
    Mol Pharmacol; 1979 Mar; 15(2):197-212. PubMed ID: 470928
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and cholinergic activity of some structural analogs of pilocarpine.
    Borne RF; Aboul-Enein HY; Waters IW; Hicks J
    J Med Chem; 1973 Mar; 16(3):245-7. PubMed ID: 4733105
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of the molecular structure and mechanisms of pond snail neuron cholinoreceptor function by means of in vivo chemical modification].
    Brezhestovskiĭ PD; Vul'fius EA; Il'in VI; Iurchenko OP
    Biofizika; 1979; 24(5):854-9. PubMed ID: 486560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and stereochemical requirements for muscarinic receptor binding.
    Aronstam RS; Triggle DJ; Eldefrawi ME
    Mol Pharmacol; 1979 Mar; 15(2):227-34. PubMed ID: 470929
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of anticholinergic, muscarinic receptor blockaders on the mouth mucosa].
    Markkanen YJ
    Suom Hammaslaakarilehti; 1987 Feb; 34(3):101-7. PubMed ID: 3473590
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimuscarinic agents: furan analogs of benzilate esters.
    Stubbins JF; Hudgins PM; Murphy DC
    J Pharm Sci; 1980 May; 69(5):534-7. PubMed ID: 7381738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of some carbocyclic analogs of muscarine.
    Sundelin KG; Wiley RA; Givens RS; Rademacher DR
    J Med Chem; 1973 Mar; 16(3):235-9. PubMed ID: 4733104
    [No Abstract]   [Full Text] [Related]  

  • 20. Acetylcholine receptor of Limnaea stagnalis neurones. Study of the active site functional groups.
    Vulfius CA; Yurchenko OP; Il'in VI; Bregestovski PD; Veprintsev BN
    Prog Brain Res; 1979; 49():293-302. PubMed ID: 515434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.